OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

Reddit, Inc. (RDDT) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

RDDT · Reddit, Inc.

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 52 filings · fetched 2026-11-13T19:39:18Z

Recent reported activity

0purchase rows on this page
13sale rows on this page
221matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-05-20Filed 2026-05-22Vollero AndrewOfficer · Chief Financial Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were withheld by the Issuer to satisfy the reporting person's tax withholding obligations. Not a market sale.

References: F1

F WithholdingClass A Common Stock · Non-derivative10,320D154.88DirectForm 4 ↗0001713445-26-000074
2026-05-20Filed 2026-05-22Reynolds Michelle MarieOfficer · Chief Accounting Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were withheld by the Issuer to satisfy the reporting person's tax withholding obligations. Not a market sale.

References: F1

F WithholdingClass A Common Stock · Non-derivative1,265D154.88DirectForm 4 ↗0001713445-26-000073
2026-05-18Filed 2026-05-20Wong Jennifer L.Officer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.

F2 The sales were executed in multiple trades at prices ranging from $154.18 to $155.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 8 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $155.19 to $155.94.

F4 The sales were executed in multiple trades at prices ranging from $156.20 to $157.19.

F5 The sales were executed in multiple trades at prices ranging from $157.20 to $158.19.

F6 The sales were executed in multiple trades at prices ranging from $158.22 to $159.20.

F7 The sales were executed in multiple trades at prices ranging from $159.23 to $160.20.

F8 The sales were executed in multiple trades at prices ranging from $160.24 to $160.80.

F9 The stock option is fully vested and currently exercisable.

References: F1, F9

M Exercise / conversionStock Option (Right to Buy) · Derivative39,167D0DirectForm 4 ↗0001663651-26-000012
2026-05-18Filed 2026-05-20Wong Jennifer L.Officer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.

F2 The sales were executed in multiple trades at prices ranging from $154.18 to $155.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 8 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $155.19 to $155.94.

F4 The sales were executed in multiple trades at prices ranging from $156.20 to $157.19.

F5 The sales were executed in multiple trades at prices ranging from $157.20 to $158.19.

F6 The sales were executed in multiple trades at prices ranging from $158.22 to $159.20.

F7 The sales were executed in multiple trades at prices ranging from $159.23 to $160.20.

F8 The sales were executed in multiple trades at prices ranging from $160.24 to $160.80.

F9 The stock option is fully vested and currently exercisable.

References: F1, F8

S Sale (market/private)Class A Common Stock · Non-derivative2,500D160.47DirectForm 4 ↗0001663651-26-000012
2026-05-18Filed 2026-05-20Wong Jennifer L.Officer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.

F2 The sales were executed in multiple trades at prices ranging from $154.18 to $155.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 8 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $155.19 to $155.94.

F4 The sales were executed in multiple trades at prices ranging from $156.20 to $157.19.

F5 The sales were executed in multiple trades at prices ranging from $157.20 to $158.19.

F6 The sales were executed in multiple trades at prices ranging from $158.22 to $159.20.

F7 The sales were executed in multiple trades at prices ranging from $159.23 to $160.20.

F8 The sales were executed in multiple trades at prices ranging from $160.24 to $160.80.

F9 The stock option is fully vested and currently exercisable.

References: F1, F7

S Sale (market/private)Class A Common Stock · Non-derivative6,954D159.66DirectForm 4 ↗0001663651-26-000012
2026-05-18Filed 2026-05-20Wong Jennifer L.Officer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.

F2 The sales were executed in multiple trades at prices ranging from $154.18 to $155.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 8 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $155.19 to $155.94.

F4 The sales were executed in multiple trades at prices ranging from $156.20 to $157.19.

F5 The sales were executed in multiple trades at prices ranging from $157.20 to $158.19.

F6 The sales were executed in multiple trades at prices ranging from $158.22 to $159.20.

F7 The sales were executed in multiple trades at prices ranging from $159.23 to $160.20.

F8 The sales were executed in multiple trades at prices ranging from $160.24 to $160.80.

F9 The stock option is fully vested and currently exercisable.

References: F1, F6

S Sale (market/private)Class A Common Stock · Non-derivative16,914D158.85DirectForm 4 ↗0001663651-26-000012
2026-05-18Filed 2026-05-20Wong Jennifer L.Officer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.

F2 The sales were executed in multiple trades at prices ranging from $154.18 to $155.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 8 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $155.19 to $155.94.

F4 The sales were executed in multiple trades at prices ranging from $156.20 to $157.19.

F5 The sales were executed in multiple trades at prices ranging from $157.20 to $158.19.

F6 The sales were executed in multiple trades at prices ranging from $158.22 to $159.20.

F7 The sales were executed in multiple trades at prices ranging from $159.23 to $160.20.

F8 The sales were executed in multiple trades at prices ranging from $160.24 to $160.80.

F9 The stock option is fully vested and currently exercisable.

References: F1, F5

S Sale (market/private)Class A Common Stock · Non-derivative6,458D157.67DirectForm 4 ↗0001663651-26-000012
2026-05-18Filed 2026-05-20Wong Jennifer L.Officer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.

F2 The sales were executed in multiple trades at prices ranging from $154.18 to $155.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 8 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $155.19 to $155.94.

F4 The sales were executed in multiple trades at prices ranging from $156.20 to $157.19.

F5 The sales were executed in multiple trades at prices ranging from $157.20 to $158.19.

F6 The sales were executed in multiple trades at prices ranging from $158.22 to $159.20.

F7 The sales were executed in multiple trades at prices ranging from $159.23 to $160.20.

F8 The sales were executed in multiple trades at prices ranging from $160.24 to $160.80.

F9 The stock option is fully vested and currently exercisable.

References: F1, F4

S Sale (market/private)Class A Common Stock · Non-derivative4,941D156.92DirectForm 4 ↗0001663651-26-000012
2026-05-18Filed 2026-05-20Wong Jennifer L.Officer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.

F2 The sales were executed in multiple trades at prices ranging from $154.18 to $155.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 8 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $155.19 to $155.94.

F4 The sales were executed in multiple trades at prices ranging from $156.20 to $157.19.

F5 The sales were executed in multiple trades at prices ranging from $157.20 to $158.19.

F6 The sales were executed in multiple trades at prices ranging from $158.22 to $159.20.

F7 The sales were executed in multiple trades at prices ranging from $159.23 to $160.20.

F8 The sales were executed in multiple trades at prices ranging from $160.24 to $160.80.

F9 The stock option is fully vested and currently exercisable.

References: F1, F3

S Sale (market/private)Class A Common Stock · Non-derivative600D155.58DirectForm 4 ↗0001663651-26-000012
2026-05-18Filed 2026-05-20Wong Jennifer L.Officer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.

F2 The sales were executed in multiple trades at prices ranging from $154.18 to $155.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 8 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $155.19 to $155.94.

F4 The sales were executed in multiple trades at prices ranging from $156.20 to $157.19.

F5 The sales were executed in multiple trades at prices ranging from $157.20 to $158.19.

F6 The sales were executed in multiple trades at prices ranging from $158.22 to $159.20.

F7 The sales were executed in multiple trades at prices ranging from $159.23 to $160.20.

F8 The sales were executed in multiple trades at prices ranging from $160.24 to $160.80.

F9 The stock option is fully vested and currently exercisable.

References: F1, F2

S Sale (market/private)Class A Common Stock · Non-derivative800D154.6DirectForm 4 ↗0001663651-26-000012
2026-05-18Filed 2026-05-20Wong Jennifer L.Officer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.

F2 The sales were executed in multiple trades at prices ranging from $154.18 to $155.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 8 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $155.19 to $155.94.

F4 The sales were executed in multiple trades at prices ranging from $156.20 to $157.19.

F5 The sales were executed in multiple trades at prices ranging from $157.20 to $158.19.

F6 The sales were executed in multiple trades at prices ranging from $158.22 to $159.20.

F7 The sales were executed in multiple trades at prices ranging from $159.23 to $160.20.

F8 The sales were executed in multiple trades at prices ranging from $160.24 to $160.80.

F9 The stock option is fully vested and currently exercisable.

References: F1

M Exercise / conversionClass A Common Stock · Non-derivative39,167A5.35DirectForm 4 ↗0001663651-26-000012
2026-05-15Filed 2026-05-19Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

F2 The sales were executed in multiple trades at prices ranging from $153.64 to $154.63. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 7 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $154.69 to $155.67.

F4 The sales were executed in multiple trades at prices ranging from $155.73 to $156.71.

F5 The sales were executed in multiple trades at prices ranging from $156.73 to $157.72.

F6 The sales were executed in multiple trades at prices ranging from $157.73 to $158.71.

F7 The sales were executed in multiple trades at prices ranging from $158.73 to $159.07.

F8 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.

F9 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F10 The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.

References: F10

M Exercise / conversionClass B Common Stock · Derivative3,954A0IndirectBy The XYZ Revocable TrustForm 4 ↗0001827011-26-000022
2026-05-15Filed 2026-05-19Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

F2 The sales were executed in multiple trades at prices ranging from $153.64 to $154.63. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 7 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $154.69 to $155.67.

F4 The sales were executed in multiple trades at prices ranging from $155.73 to $156.71.

F5 The sales were executed in multiple trades at prices ranging from $156.73 to $157.72.

F6 The sales were executed in multiple trades at prices ranging from $157.73 to $158.71.

F7 The sales were executed in multiple trades at prices ranging from $158.73 to $159.07.

F8 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.

F9 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F10 The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.

References: F9

M Exercise / conversionStock Option (Right to Buy) · Derivative3,954D0IndirectBy The XYZ Revocable TrustForm 4 ↗0001827011-26-000022
2026-05-15Filed 2026-05-19Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

F2 The sales were executed in multiple trades at prices ranging from $153.64 to $154.63. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 7 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $154.69 to $155.67.

F4 The sales were executed in multiple trades at prices ranging from $155.73 to $156.71.

F5 The sales were executed in multiple trades at prices ranging from $156.73 to $157.72.

F6 The sales were executed in multiple trades at prices ranging from $157.73 to $158.71.

F7 The sales were executed in multiple trades at prices ranging from $158.73 to $159.07.

F8 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.

F9 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F10 The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.

References: F9

M Exercise / conversionStock Option (Right to Buy) · Derivative18,000D0IndirectBy The XYZ Revocable TrustForm 4 ↗0001827011-26-000022
2026-05-15Filed 2026-05-19Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

F2 The sales were executed in multiple trades at prices ranging from $153.64 to $154.63. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 7 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $154.69 to $155.67.

F4 The sales were executed in multiple trades at prices ranging from $155.73 to $156.71.

F5 The sales were executed in multiple trades at prices ranging from $156.73 to $157.72.

F6 The sales were executed in multiple trades at prices ranging from $157.73 to $158.71.

F7 The sales were executed in multiple trades at prices ranging from $158.73 to $159.07.

F8 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.

F9 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F10 The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.

References: F1, F7

S Sale (market/private)Class A Common Stock · Non-derivative300D158.96IndirectBy The XYZ Revocable TrustForm 4 ↗0001827011-26-000022
2026-05-15Filed 2026-05-19Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

F2 The sales were executed in multiple trades at prices ranging from $153.64 to $154.63. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 7 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $154.69 to $155.67.

F4 The sales were executed in multiple trades at prices ranging from $155.73 to $156.71.

F5 The sales were executed in multiple trades at prices ranging from $156.73 to $157.72.

F6 The sales were executed in multiple trades at prices ranging from $157.73 to $158.71.

F7 The sales were executed in multiple trades at prices ranging from $158.73 to $159.07.

F8 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.

F9 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F10 The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.

References: F1, F6

S Sale (market/private)Class A Common Stock · Non-derivative7,467D158.2IndirectBy The XYZ Revocable TrustForm 4 ↗0001827011-26-000022
2026-05-15Filed 2026-05-19Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

F2 The sales were executed in multiple trades at prices ranging from $153.64 to $154.63. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 7 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $154.69 to $155.67.

F4 The sales were executed in multiple trades at prices ranging from $155.73 to $156.71.

F5 The sales were executed in multiple trades at prices ranging from $156.73 to $157.72.

F6 The sales were executed in multiple trades at prices ranging from $157.73 to $158.71.

F7 The sales were executed in multiple trades at prices ranging from $158.73 to $159.07.

F8 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.

F9 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F10 The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.

References: F1, F5

S Sale (market/private)Class A Common Stock · Non-derivative4,211D157.17IndirectBy The XYZ Revocable TrustForm 4 ↗0001827011-26-000022
2026-05-15Filed 2026-05-19Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

F2 The sales were executed in multiple trades at prices ranging from $153.64 to $154.63. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 7 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $154.69 to $155.67.

F4 The sales were executed in multiple trades at prices ranging from $155.73 to $156.71.

F5 The sales were executed in multiple trades at prices ranging from $156.73 to $157.72.

F6 The sales were executed in multiple trades at prices ranging from $157.73 to $158.71.

F7 The sales were executed in multiple trades at prices ranging from $158.73 to $159.07.

F8 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.

F9 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F10 The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.

References: F1, F4

S Sale (market/private)Class A Common Stock · Non-derivative3,322D156.4IndirectBy The XYZ Revocable TrustForm 4 ↗0001827011-26-000022
2026-05-15Filed 2026-05-19Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

F2 The sales were executed in multiple trades at prices ranging from $153.64 to $154.63. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 7 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $154.69 to $155.67.

F4 The sales were executed in multiple trades at prices ranging from $155.73 to $156.71.

F5 The sales were executed in multiple trades at prices ranging from $156.73 to $157.72.

F6 The sales were executed in multiple trades at prices ranging from $157.73 to $158.71.

F7 The sales were executed in multiple trades at prices ranging from $158.73 to $159.07.

F8 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.

F9 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F10 The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.

References: F1, F3

S Sale (market/private)Class A Common Stock · Non-derivative2,000D155.22IndirectBy The XYZ Revocable TrustForm 4 ↗0001827011-26-000022
2026-05-15Filed 2026-05-19Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

F2 The sales were executed in multiple trades at prices ranging from $153.64 to $154.63. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 7 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $154.69 to $155.67.

F4 The sales were executed in multiple trades at prices ranging from $155.73 to $156.71.

F5 The sales were executed in multiple trades at prices ranging from $156.73 to $157.72.

F6 The sales were executed in multiple trades at prices ranging from $157.73 to $158.71.

F7 The sales were executed in multiple trades at prices ranging from $158.73 to $159.07.

F8 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.

F9 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F10 The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.

References: F1, F2

S Sale (market/private)Class A Common Stock · Non-derivative700D154.19IndirectBy The XYZ Revocable TrustForm 4 ↗0001827011-26-000022
2026-05-15Filed 2026-05-19Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

F2 The sales were executed in multiple trades at prices ranging from $153.64 to $154.63. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 7 to this Form 4.

F3 The sales were executed in multiple trades at prices ranging from $154.69 to $155.67.

F4 The sales were executed in multiple trades at prices ranging from $155.73 to $156.71.

F5 The sales were executed in multiple trades at prices ranging from $156.73 to $157.72.

F6 The sales were executed in multiple trades at prices ranging from $157.73 to $158.71.

F7 The sales were executed in multiple trades at prices ranging from $158.73 to $159.07.

F8 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.

F9 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F10 The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.

References: F1

M Exercise / conversionClass A Common Stock · Non-derivative18,000A25.29IndirectBy The XYZ Revocable TrustForm 4 ↗0001827011-26-000022

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.